<DOC>
	<DOCNO>NCT00004073</DOCNO>
	<brief_summary>RATIONALE : Suramin may stop growth glioblastoma multiforme stop blood flow tumor . Radiation therapy use high-energy x-rays damage tumor cell . Combining suramin radiation therapy may effective treatment glioblastoma multiforme . PURPOSE : Phase II trial study effectiveness suramin plus radiation therapy treat patient newly diagnose glioblastoma multiforme .</brief_summary>
	<brief_title>Suramin Plus Radiation Therapy Treating Patients With Newly Diagnosed Glioblastoma Multiforme</brief_title>
	<detailed_description>OBJECTIVES : I. Assess toxicity suramin administer prior concurrent radiotherapy patient newly diagnose high grade glioblastoma multiforme . II . Evaluate regimen term survival patient population . OUTLINE : Patients receive suramin IV 2 hour initial dose 1 hour subsequent dose daily 5 day week 1 . Patients receive concurrent radiotherapy daily suramin IV 1 hour twice weekly week 2-7 . Patients stable responsive disease receive second course suramin twice weekly week 20-24 . Treatment continue absence disease progression unacceptable toxicity . Patients follow every 2 month disease progression start new therapy monthly survival . PROJECTED ACCRUAL : A total 54 patient accrue study 1.5 year .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Suramin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm supratentorial glioblastoma multiforme No prior intracranial intratumoral hemorrhage PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : Greater 2 month Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hemoglobin least 9 g/dL No history bleed disorder would interfere protocol therapy Hepatic : Bilirubin great 1.5 mg/dL Transaminases great 4 time upper limit normal Renal : Creatinine great 1.7 mg/dL Cardiovascular : No suspected disseminate intravascular coagulation No history venous thrombosis require coumadin Other : No serious concurrent infection medical illness would prevent compliance No malignancy within past 5 year except curatively treat basal cell skin cancer carcinoma situ cervix Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No prior immunotherapy biologic agent ( e.g. , immunotoxins , immunoconjugates , antisense , peptide receptor antagonist , interferon , interleukin , lymphokine activate killer cell , tumor infiltrating lymphocyte , gene therapy ) brain tumor Chemotherapy : No prior chemotherapy brain tumor Endocrine therapy : No prior hormonal therapy brain tumor Prior glucocorticoid allow Maintenance 5 day stable corticosteroid regimen require postsurgery Radiotherapy : No prior radiotherapy brain tumor Surgery : Prior surgery brain tumor allow recovered immediate post operative period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>